4,5,6,7-Tetrahydro-1,3-Benzothiazole-2,6-Diamine

Commercially, the available supply of racemic 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine originates predominantly from the demand for its resolved (S)-enantiomer in central nervous system therapeutics. The molecule’s structural architecture—a saturated cyclohexane ring fused to a thiazole core with strategically positioned primary amine groups—generates specific reactivity profiles exploited across divergent process chemistries. The following application partitions describe verified industrial consumption points, processing boundary conditions, and the quantitative regulatory frameworks governing each downstream segment.

Resolving the (S)-enantiomer for Pramipexole Dihydrochloride Monohydrate API

The globally highest-volume consumption channel for 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine remains its use as the penultimate chiral intermediate in the synthesis of pramipexole, a non-ergot D2/D3 dopamine agonist. In this sequence, the racemic diamine undergoes optical resolution with a chiral resolving agent—typically di-p-toluoyl-D-tartaric acid or dibenzoyl-D-tartaric acid in an aqueous methanolic system at 55-65°C—to isolate the required (S)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole diastereomeric salt. The crystallized salt is liberated with aqueous sodium hydroxide and extracted into dichloromethane, with enantiomeric excess typically exceeding 99.5% when monitored by chiral HPLC using a Chiralpak IA column and hexane-ethanol-diethylamine mobile phase. The resolved (S)-diamine is then subjected to reductive alkylation with propionaldehyde under hydrogen pressure in the presence of Raney nickel, followed by hydrochloric acid treatment to yield pramipexole dihydrochloride monohydrate meeting Ph.Eur. monograph requirements. Process waste streams containing the undesired (R)-enantiomer are often racemized under strongly basic conditions at elevated temperature to recover additional racemic feedstock, improving overall mass efficiency. Industry compliance standards: ICH Q7A (Section 7.3 for recovery and re-processing), ICH Q3C residual solvent limits (methanol <3000 ppm, dichloromethane <600 ppm), and Ph.Eur. monograph 01/2024:2416 for pramipexole dihydrochloride monohydrate substance specification. Stoichiometric incorporation: The (S)-diamine is charged at 1.02-1.10 molar equivalents relative to propionaldehyde; unreacted diamine is removed during API crystallization and must be controlled below 0.10% in the final product per pharmacopoeial related substances criteria. Downstream manufacturing process: After resolution and liberation, the (S)-free base is dissolved in methanol, treated with propionaldehyde at 0-5°C to control exotherm, then hydrogenated at 3-5 bar using Raney Ni #2800 slurry in a jacketed hydrogenation vessel equipped with a hollow-shaft self-inducing gas turbine. Post-filtration of catalyst, the methanolic solution is acidified with concentrated pharmaceutical-grade HCl to pH 1.5-2.0, and the crude pramipexole dihydrochloride is recrystallized from aqueous isopropanol to achieve polymorphic Form I consistency. Terminal finished articles: Immediate-release tablets (0.125 mg, 0.25 mg, 0.5 mg, 1.0 mg, 1.5 mg pramipexole base) and extended-release tablets (0.375 mg to 4.5 mg once-daily) manufactured by Boehringer Ingelheim under the Mirapex and Mirapex ER registered trade names, with generic equivalents produced by multiple ANDA holders in the United States under FDA Orange Book therapeutic equivalence code AB.

Why Central Nervous System Drug Discovery Pipelines Procure This Scaffold?

The 2,6-diamino-tetrahydrobenzothiazole core features in numerous published patent families targeting dopamine D2, D3, and D4 receptor subtypes as well as serotonin 5-HT1A agonists. Medicinal chemistry teams source the racemic material to construct focused libraries through selective functionalization at the 2-amino or 6-amino position without requiring immediate chiral resolution, deferring enantiomer separation until lead optimization phases. Compliance framework: Materials supplied to discovery chemistry groups typically adhere to research-grade specifications with Certificate of Analysis documenting purity by HPLC (≥97.0%), residual water by Karl Fischer titration (≤0.5%), and residual solvents by headspace GC conforming to ICH Q3C. Controlled substance precursor status in the intended jurisdiction must be verified; this compound is not scheduled under United Nations Convention on Psychotropic Substances lists, but import declarations should reference CAS [144625-52-3] (racemic) or the specific enantiomer CAS where applicable to avoid customs delays. Incorporation ratio in parallel synthesis: In building block workflows, the diamine is typically dispensed as a 0.2 M solution in N-methyl-2-pyrrolidone or dimethylacetamide, with automated liquid handlers programming 1.05-1.20 equivalents relative to the monomeric electrophile (acyl chlorides, sulfonyl chlorides, isocyanates) to compensate for amine reactivity differences at the 2- versus 6-position. The N2 position of the thiazole ring exhibits lower nucleophilicity due to the electron-withdrawing effect of the adjacent sulfur and nitrogen heteroatoms, necessitating the slight stoichiometric excess to drive desired 2-acylated product ratios above 85% in competition with 6-acylation. Process technology: Synthesis of research analogues proceeds in 8-40 mL septum-capped microwave vials with irradiation at 100-150°C for 20-60 minutes in a Biotage Initiator or equivalent single-mode reactor, followed by scavenger resin treatment (polymer-bound trisamine or isocyanate resin) to remove unreacted electrophile before silica gel cartridge purification on an automated flash chromatography system (Isolera or CombiFlash). Structure confirmation for each library member relies on UPLC-MS with electrospray ionization and 1H NMR in DMSO-d6, with the characteristic tetrahydrobenzothiazole C4 and C5 methylene proton signals appearing as overlapping multiplets between δ 2.5-3.2 ppm. End-product categories: Preclinical candidate molecules, radioligand precursors for PET tracer development, and in vitro pharmacological tool compounds for dopamine receptor binding assays using transfected CHO cells expressing human D2S, D2L, and D3 receptors (Ki determination per Cerep or Eurofins Panlabs standard protocols).

In power module encapsulation, the maximum continuous junction temperature specification for next-generation silicon carbide devices demands molding compounds with glass transition temperatures exceeding 200°C while maintaining single-digit moisture absorption at 85°C/85% RH. Conventional 4,4′-diaminodiphenylmethane and methylene dianiline hardeners, though providing adequate thermal performance, are increasingly restricted under REACH Annex XVII due to carcinogenicity classifications. The alicyclic architecture of 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine introduces a semi-rigid fused heterocycle that does not undergo the metabolic N-acetylation or ring-hydroxylation pathways characteristic of aromatic amines, which partially mitigates the toxicological profile while preserving thermal backbone rigidity. The two primary amine groups reside on electronically distinct positions: the C2 amine is directly conjugated to the thiazole π-system and displays slightly attenuated nucleophilicity, whereas the C6 amine is insulated by the saturated cyclohexane bridge and reacts with epoxy rings at rates comparable to isophorone diamine. Formulators adjust stoichiometry based on the experimentally determined amine hydrogen equivalent weight (AHEW) of 43-45 g/eq, which accounts for both amine protons and their differing reactivities; theoretical AHEW calculates to 42.1 g/eq for the four active hydrogens, but steric shielding raises the practical value. Formulation addition level: When curing a bisphenol A/F hybrid epoxy novolac resin with an epoxide equivalent weight of 175 g/eq (supplier: Huntsman Tactix 742), the recommended hardener loading is 25.0 parts per hundred resin (phr), equating to a 1.00:1.05 epoxy-to-amine hydrogen molar ratio. Variations as small as ±2 phr shift the crosslink density sufficiently to alter glass transition by 8-12°C measured by dynamic mechanical analysis (ASTM D7028) at a frequency of 1 Hz and ramp rate of 3°C/min. B-staging of the formulation on treated filler in a planetary mixer under 25 mbar vacuum results in a viscosity rise from 1,200 mPa·s to 8,000-12,000 mPa·s at 40°C within 45-60 minutes, calling for transfer molding equipment with clamp force capacities of 100-300 metric tons depending on the number of cavities. Relevant compliance standards: IPC-4101E (slash sheet /126 for high-Tg rigid laminates), UL 94 V-0 flammability classification, IEC 61287-1 for traction converter insulator qualification, and RA 10-2009 for REACH compliance of imported formulations containing substances above 1 tonne per annum. Manufacturing process sequence: Vacuum-assisted dispensing of two-component liquid epoxy formulation into preheated 80°C steel molds, followed by a staged cure bake profile of 120°C / 2 hours, 160°C / 1 hour, and 200°C / 4 hours under nitrogen purge to achieve conversion exceeding 98% monitored by differential scanning calorimetry (residual exotherm below 5 J/g per ASTM D3418). Finished article types: Insulated-gate bipolar transistor (IGBT) module casings, high-voltage bushing insulators for railway traction converters rated at 3.3 kV and 6.5 kV, and stators for oil-immersed downhole pump motors operating at ambient temperatures up to 180°C.

Light Stabilizer Intermediates Without Benzotriazole Motifs

Regulatory pressure on benzotriazole ultraviolet absorbers—specifically their classification under REACH as Substances of Very High Concern due to persistent, bioaccumulative, and toxic (PBT) properties for select homologues—has intensified the search for photostabilizers that retain strong UV absorbance in the 290-350 nm region without the benzotriazole nitrogen backbone. The condensation of 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine with substituted salicylaldehydes or hydroxyphenyl carboxylic acid derivatives yields a class of hydroxyphenyl-tetrahydrobenzothiazole heterocycles that undergo excited-state intramolecular proton transfer (ESIPT) to dissipate absorbed UV energy as heat. The C6 primary amine serves as the anchor point for attaching the hydroxyphenyl chromophore, while the C2 amine can be further alkylated or acylated to tune compatibility with host polymer matrices. Addition ratio in final coating formulation: When the synthesized UV absorber is introduced into a 2K acrylic-polyurethane automotive OEM clearcoat based on a hexamethylene diisocyanate trimer hardener, it is pre-dissolved in butyl acetate at 50% solids and dosed at 0.8-1.5 wt% on total resin solids. Below 0.5 wt%, protection of the underlying basecoat against photo-oxidative degradation is insufficient, with ΔE* color shift exceeding 3.0 units after 2,000 hours of xenon arc exposure (SAE J2527); above 2.0 wt%, the absorber begins to plasticize the film, dropping pendulum hardness (ISO 1522) by 15-20% relative to unmodified clearcoat. Manufacturing protocol for the intermediate: The absorber synthesis is conducted under nitrogen in dimethylformamide at 110-120°C using 1.00 mole of the diamine and 1.05 moles of 2-hydroxy-4-methoxybenzophenone-3-carboxylic acid chloride in the presence of 1.20 moles of triethylamine as acid scavenger, yielding the 6-amido derivative with selectivity over the 2-position exceeding 90%. After aqueous workup and recrystallization from toluene, the intermediate is assessed for absorbance profile by UV-Vis spectrophotometry (dissolved in ethyl acetate at 10 mg/L), with the λmax typically centered at 328-334 nm and molar extinction coefficient above 20,000 L mol⁻¹ cm⁻¹. Compliance specifications: For indirect food-contact approval under FDA 21 CFR 175.300 (resinous and polymeric coatings), the migrated quantity of the stabilizing additive must not exceed 50 ppb in food simulants; formulators therefore demand that the neat absorber contains less than 0.15% of unreacted free aromatic amine, quantifiable by LC-MS/MS with a limit of detection at 0.01 ppm. Further testing according to EN 71-3 (migration of certain elements) and PAH content per AfPS GS 2019:01 PAK is required for toys and consumer articles finished with stabilized coatings. End products: UV-cured wood flooring topcoats, polyurethane-based automotive refinish clears, and crosslinked polyester coil coatings for architectural aluminum curtain wall panels requiring 10-year South Florida exposure warranties with 50% gloss retention.

During matrix acidizing of carbonate reservoirs, the corrosion rate of N80 tubing steel in 15 wt% HCl at 60°C without inhibitor can exceed 100 mm/year, leading to catastrophic tubing failure within hours of pump displacement. Heterocyclic sulfur-nitrogen compounds structurally related to 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine adsorb onto mild steel surfaces through coordinate bonding of both sulfur and nitrogen lone pairs to vacant d-orbitals of iron, forming a protective chemisorbed film that suppresses both the cathodic hydrogen evolution and anodic iron dissolution reactions. Weight loss evaluation per ASTM G31-72 on API 5CT N80 grade coupons (surface area 28 cm², polished to 600 grit finish) immersed in uninhibited 15% HCl for 6 hours at 60°C provides baseline corrosion rates of 98-115 mm/year. Published experimental data for this specific diamine in acidizing environments remain limited; however, structurally analogous benzothiazole-2-thiol corrosion inhibitors show inhibition efficiencies exceeding 95% at dosing levels between 0.2 g/L and 1.0 g/L under identical conditions, and the primary amine groups on this compound are believed to enhance adsorption onto the negatively charged steel surface at potentials cathodic to the point of zero charge. Recommended addition rate for evaluation: Acidizing formulations incorporating this diamine as a secondary inhibitor synergist are typically tested in the 0.3-0.8 wt% range (based on total acid solution mass) alongside commercial acetylenic alcohol primary inhibitors (e.g., propargyl alcohol at 0.5-1.0 vol%) and an iodide salt intensifier (0.02-0.05 M potassium iodide). The presence of the free amine groups necessitates careful pH buffering of the acid blend; formulators should pre-mix the diamine with glacial acetic acid (≤5 wt%) before addition to the hydrochloric acid concentrate to prevent rapid salt precipitation. Compliance and testing hierarchy: Corrosion inhibitor performance qualification for oilfield service follows NACE TM0169-2012 (gravimetric) or NACE TM0284-2016 (electrochemical) protocols, with acceptance criteria for low-carbon steel typically set at ≤0.05 lb/ft² mass loss over the exposure period. Environmental compatibility is assessed through OECD 306 biodegradation in seawater and OSPAR Commission harmonized offshore chemical notification format if the inhibitor package is intended for North Sea discharge. Operational processing specifics: The acidizing fluid batch is mixed in frac tanks at the wellsite; the inhibitor package including the dissolved diamine is metered into the suction side of the positive displacement pump through a chemical injection skid to ensure homogeneous dispersion before the fluid enters coiled tubing. Well shut-in times range from 2-8 hours depending on formation temperature, during which the inhibitor film must remain persistent. Terminal application endpoints: Carbonate reservoir matrix stimulation treatments (limestone and dolostone formations in the Permian Basin, Ghawar Field, and Pre-salt Santos Basin), acid descaling of crude unit overhead condensers during chemical cleaning turnarounds, and pickling of OCTG (oil country tubular goods) at the pipe mill or threading facility before phosphate coating application.